CN105381466A - Photo-magnetic and temperature-sensitive nano-composite drug carrier and preparation method thereof - Google Patents

Photo-magnetic and temperature-sensitive nano-composite drug carrier and preparation method thereof Download PDF

Info

Publication number
CN105381466A
CN105381466A CN201510793864.8A CN201510793864A CN105381466A CN 105381466 A CN105381466 A CN 105381466A CN 201510793864 A CN201510793864 A CN 201510793864A CN 105381466 A CN105381466 A CN 105381466A
Authority
CN
China
Prior art keywords
quantum dot
zns
nano
sio
temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201510793864.8A
Other languages
Chinese (zh)
Other versions
CN105381466B (en
Inventor
曹健
牛海凤
杨景海
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jilin Normal University
Original Assignee
Jilin Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jilin Normal University filed Critical Jilin Normal University
Priority to CN201510793864.8A priority Critical patent/CN105381466B/en
Publication of CN105381466A publication Critical patent/CN105381466A/en
Application granted granted Critical
Publication of CN105381466B publication Critical patent/CN105381466B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention provides a photo-magnetic and temperature-sensitive nano-composite drug carrier and a preparation method thereof, belongs to the field of drug carriers, and provides a preparation method to solve the problems that the prior art is relatively poor in fluorescence, magnetic property and thermosensitivity in preparation of the photo-magnetic and temperature-sensitive nano-composite drug carrier, and the preparation steps are adverse to industrial production. The method comprises the following steps: with n-isopropylacrylamide, tetraethoxysilane, ZnS:Mn<2+> quantum dots and Fe3O4 quantum dots as main raw materials, firstly, carrying out surface modification on the Fe3O4 quantum dots by oleinic acid; secondly, simultaneously embedding the ZnS:Mn<2+> quantum dots and the Fe3O4 quantum dots into SiO2; thirdly, modifying double bonds on the SiO2 surface by a silane coupling agent; and finally coating a polymer PNIPAAm through free radical polymerization, and achieving preparation of ZnS:Mn<2+> quantum dots/Fe3O4 quantum dots/SiO2/PNIPAAm of the photo-magnetic and temperature-sensitive nano-composite drug carrier.

Description

A kind of optomagnetic temperature-sensitive nano combination drug carrier and preparation method thereof
Technical field
The invention belongs to pharmaceutical carrier field, be specifically related to a kind of luminescence, magnetic, temperature sensitive complex drug carrier material and preparation method thereof.
Background technology
In Current cancer therapeutic process, ubiquitous problem is cancer therapy drug that is oral or injection is all Formulations for systemic administration, and medicine, not only to cancer cell, also can implement drug effect to healthy cell, and patients immune system is worsened further.Therefore, be badly in need of the nano combined pharmaceutical carrier of design Novel non-toxic, allow drug specificity aim at cancerous cell and not damaging adjacent healthy cell, thus improve the therapeutic efficiency to cancer, and significantly reduce the infringement to human body.
Temperature sensitive type poly compound PNIPAAm (PNIPAM) has good biocompatibility, biodegradability, and temperature switch characteristic, and preparation method is simple, good stability.In recent years, utilize PNIPAAm and there is light, the inorganic composite materials of magnetic property builds the extensive concern that nano combined pharmaceutical carrier obtains people, utilize photoluminescent property can realize its in-vivo imaging and medicine tracking, utilize magnetic orientation technology to be led by pharmaceutical carrier tumor tissues, utilize the Thermo-sensitive of polymer to realize the controllable release of medicine.Although be very promising medical carrier by PNIPAAm and inorganic nano material compound, preparation process also needs to overcome an a lot of difficult problem.A main difficult problem has two, and one is the fluorescent quenching problem of magnetic material to fluorescent material, and one is the connectivity problem of inorganic material and polymer P NIPAAm.Directly affects the magnetic of product, fluorescence and temperature sensitivity.In addition existing preparation method step is restive, and prepared complex character heterogeneity, not easily realizes industrialization.
Summary of the invention
In order to solve above-mentioned difficulties, optomagnetic temperature-sensitive nano combination drug carrier provided by the present invention, with ZnS:Mn 2+quantum dot as fluorescence source, with Fe 3o 4quantum dot, as magnetic source and with after oleic acid finishing, distinguishes coated Si O 2, re-use silane coupler to SiO 2carry out finishing, finally coated PNIPAM again, form ZnS:Mn 2+quantum dot/Fe 3o 4quantum dot/SiO 2/ PNIPAM structure.
The preparation method of described optomagnetic temperature-sensitive nano combination drug carrier is as follows:
One, by 300 ~ 600mgFe 3o 4quantum dot is scattered in 5 ~ 20ml water, adds the oleic acid of water volume 15 ~ 50%, reacts 1 ~ 6h, obtain the Fe of oleic acid modified under 20 ~ 60 DEG C of conditions 3o 4quantum dot.
Two, by the Fe after oleic acid modified 3o 4quantum dot washing, dry, pulverize after be scattered in cyclohexane extraction, obtain Fe 3o 4quantum dot ring hexane solution.
Three, by ZnS:Mn 2+quantum dot is scattered in cyclohexane extraction, obtains ZnS:Mn 2+quantum dot ring hexane solution.
Four, by polyoxyethylenes (5) nonylplenyl ether, branching (IgepalCO-520) is scattered in cyclohexane extraction, and IgepalCO-520 is 0.06 ~ 0.07:1 with the ratio of the addition of cyclohexane extraction, adds ZnS:Mn 2+the cyclohexane solution of quantum dot and Fe 3o 4quantum dot ring hexane solution, is dispersed to evenly, and add ammonia and regulate pH to alkalescence, add the ethyl orthosilicate (TEOS) of cyclohexane extraction cumulative volume 0.15% ~ 0.8%, reaction 10 ~ 40h, obtains ZnS:Mn 2+quantum dot/Fe 3o 4quantum dot/SiO 2nano-complex, carries out washing after reaction terminates, dried; Wherein, the ZnS:Mn added 2+quantum dot ring hexane solution and Fe 3o 4znS:Mn in quantum dot ring hexane solution 2+quantum dot and Fe 3o 4the mass ratio of quantum dot is between 3:1 ~ 6:1.
Five, by ZnS:Mn 2+quantum dot/Fe 3o 4quantum dot/SiO 2nano-complex is dispersed in the aqueous hydrochloric acid solution of pH=3 ~ 5, and 75 ~ 85 DEG C of heating 1 ~ 2h, obtain the ZnS:Mn of surface hydroxylation 2+quantum dot/Fe 3o 4quantum dot/SiO 2nano-complex.
Six, configure the alcohol-water mixed solution (volume ratio of alcohol to water is 3 ~ 5:1) of pH=3 ~ 5.5, add silane coupler KH570, after silane coupler KH570 is hydrolyzed, add the ZnS:Mn of surface hydroxylation 2+quantum dot/Fe 3o 4quantum dot/SiO 2nano-complex carries out finishing to it, under 70 ~ 85 DEG C of conditions, react 6 ~ 7h.Wherein the addition of silane coupler KH570 is 0.25% ~ 0.5% of alcohol-water mixed solution cumulative volume.
Seven, silane coupler is modified ZnS:Mn 2+quantum dot/Fe 3o 4quantum dot/SiO 2nano-complex is scattered in water, add monomer NIPA (NIPAAm), acrylamide (AAm) and N-N-methylene-bisacrylamide (BIS), in removing reaction system after oxygen at 70 ~ 80 DEG C, adding the initiator for reaction time is namely obtain ZnS:Mn after 4 ~ 6h 2+quantum dot/Fe 3o 4quantum dot/SiO 2/ PNIPAAm nano-complex.Wherein, quality is than NIPA (NIPAAm): acrylamide (AAm): N,N methylene bis acrylamide (BIS): silane coupler modifies ZnS:Mn 2+quantum dot/Fe 3o 4quantum dot/SiO 2nano-complex=4.5 ~ 5.5:0.3 ~ 0.35:0.4 ~ 0.6:1.Described initiator is potassium peroxydisulfate (KPS).
Eight, after washing, drying, pure ZnS:Mn is obtained 2+quantum dot/Fe 3o 4quantum dot/SiO 2/ PNIPAM nano-complex.
In step 6, under 70 ~ 85 DEG C of conditions, react 6 ~ 7h be two sections and carry out: first under 70 DEG C of conditions, react 5h, then temperature is brought up to 80 ~ 85 DEG C, continue reaction 1 ~ 2h and can obtain better effect.
Beneficial effect of the present invention:
1. the present invention adopts the method for reverse micro emulsion by ZnS:Mn 2+quantum dot and Fe 3o 4quantum dot is coated on SiO simultaneously 2in, prepare the silicon ball having fluorescence and magnetic concurrently.Size uniform, size is controlled, good dispersion.
2. the inventive method has carried out finishing by KH570 silane coupler to silicon ball, substantially increases the percent grafting of surface double-bond, and then significantly improves the percent grafting of polymer on silicon ball.
3. the present invention adopts traditional radical polymerization, the silica spheres with fluorescence and magnetic is just added in preparation process, one step obtains has fluorescence, magnetic and thermally sensitive polymer based nanocomposites, method is simple, favorable repeatability, can control SiO by adjustment TEOS addition 2the thickness of clad, passes through ZnS:Mn 2+quantum dot and Fe 3o 4the additional proportion adjustment of quantum dot can control the intensity of its fluorescence and magnetic.
4. the present invention is not only simple to operate, step is clear and definite, there is environmental protection, economy, convenient, simple operation and other advantages, be easy to realize large-scale production, the simultaneously polymer nanocomposites even size distribution prepared of the method, have fluorescence, magnetic and temperature sensitivity concurrently, can use as medical carrier.
5, target product of the present invention has higher fluorescence efficiency, stronger superparamagnetism and the temperature-sensitive higher than human body temperature, accommodates very much as bio-pharmaceutical carrier.
Accompanying drawing explanation
Fig. 1 target product transmission electron microscope photo of the present invention;
Fig. 2 target product light transmittance of the present invention varies with temperature curve chart;
Fig. 3 target product fluorescence emission spectrum of the present invention;
Fig. 4 a target product aqueous dispersion of the present invention photo;
Fig. 4 b target product ultraviolet excitation of the present invention photo;
Fig. 5 hysteresis curve of the present invention (in figure, M is the sample intensity of magnetization, and H is magnetic field intensity);
Under Fig. 6 external magnetic field, target product assembles photo.
Detailed description of the invention
In the mode of specific embodiment technical solution of the present invention be further explained below and illustrate.The non-specified otherwise of following examples is carried out all at normal temperatures and pressures.
In the embodiment of the present invention use reagent as follows:
Zinc acetate (Zn (CH 3cOO) 22H 2o, Shenyang Chemical Reagent Co., Ltd., Sinopharm Group, analytical pure);
Manganese acetate (Mn (CH 3cOO) 24H 2o, Aladdin reagent, analytical pure);
Oleic acid (C 18h 34o, Shenyang Chemical Reagent Co., Ltd., Sinopharm Group, analytical pure);
Enuatrol (C 18h 33naO 2, Shenyang Chemical Reagent Co., Ltd., Sinopharm Group, chemical pure);
Ethanol (C 2h 6o, Shenyang Chemical Reagent Co., Ltd., Sinopharm Group) be analytical pure;
Nine hydrated sodium sulfide (Na 2s9H 2o, Shenyang Chemical Reagent Co., Ltd., Sinopharm Group, analytical pure);
Ferric chloride (FeCl 36H 2o, Shenyang Chemical Reagent Co., Ltd., Sinopharm Group, analytical pure);
Ferrous chloride (FeCl 24H 2o, Shenyang Chemical Reagent Co., Ltd., Sinopharm Group, analytical pure);
Ammonia (NH 3h 2o, Beijing Chemical Plant, analytical pure);
Macrogol 4000 (PEG4000) (H (OGH 2cH 2) noH, Shenyang Chemical Reagent Co., Ltd., Sinopharm Group, analytical pure);
Ethyl orthosilicate (TEOS) (C 8h 20o 4si, Shenyang Chemical Reagent Co., Ltd., Sinopharm Group, analytical pure);
Cyclohexane extraction (C 6h 12, Shenyang Chemical Reagent Co., Ltd., Sinopharm Group, analytical pure);
γ-(methacryloxypropyl) propyl trimethoxy silicane (silane coupler KH570, CH 2=C (CH 3) COOC 3h 6si (OCH 3) 3, Sigma-Aldrich, biological reagent);
NIPA (NIPAAm) (C 6h 11nO, Aladdin reagent, analytical pure);
Acrylamide (AAm) (C 3h 5nO, Aladdin reagent, top grade is pure);
Potassium peroxydisulfate (KPS) (K 2s 2o 8, Aladdin reagent, Metal Substrate (metalsbasis));
N-N-methylene-bisacrylamide (BIS) (C 7h 10n 2o 2, Aladdin reagent, electronic grade reagents);
Polyoxyethylenes (5) nonylplenyl ether, branching (IgepalCO-520) (C 2h 4o) nc 15h 24o, n ~ 5, Aladdin reagent).
Embodiment 1
(1) solvent thermal is prepared zinc sulfide and is mixed manganese quantum dot: take 0.8561gZn (CH 3cOO) 22H 2o and 0.0097gMn (CH 3cOO) 24H 2o, is poured into and is equipped with in the 250ml beaker of 7ml deionized water, and magnetic agitation 10min is to dissolving.Then in above-mentioned solution, 9.75ml oleic acid, 1.3g enuatrol, 16ml ethanol is added successively, and magnetic agitation 1h, form latex A.By 0.937gNa 2s9H 2o pours into and is equipped with in the 250ml beaker of 7ml deionized water, and magnetic agitation 10min, to dissolving, obtains sodium sulfide solution.Sodium sulfide solution is joined in latex A, and magnetic agitation 2h obtains solution B, B solution is transferred in the reactor of 50ml, reactor is put in drying baker, and the temperature arranging drying baker is 190 DEG C, reaction 12h.The product ethanol be obtained by reacting: the solution centrifugal of cyclohexane extraction=1:1 washs three times.60 DEG C of dry 5h obtain ZnS:Mn 2+quantum dot.
(2) ferroso-ferric oxide quantum dot is prepared in co-precipitation: take 2.703gFeCl 36H 2o, 1.192gFeCl 24H 2o and 10gPEG4000 joins and fills in the 500ml three-neck flask of 150ml deionized water, and mechanical agitation is to dissolving.Solution temperature is warming up to 90 DEG C, adds 100mlNH 3h 2o, stirs 2h.Products therefrom is centrifugal, wash 3 times respectively with ethanol and deionized water.By sample dispersion in aqueous, Fe is obtained 3o 4quantum dot aqueous solution.
(3) oleic acid modified ferroso-ferric oxide quantum dot: by the Fe of preparation in 300mg step (2) 3o 4quantum dot, ultrasonic 20min is dispersed in and fills in the 100ml conical flask of 20ml deionized water, then in conical flask, adds 5ml oleic acid, is placed in shaking table after continuing ultrasonic 30min, arrange shaking table temperature 60 C, rotating speed 100rpm, and the response time is 6h.After having reacted, utilize the oleic acid that washing with alcohol three removings are unnecessary, then vacuum drying 12h at 60 DEG C, pulverizes stand-by, obtains the Fe of oleic acid modified 3o 4quantum dot.By 10mgFe 3o 4quantum dot is dispersed in 10ml cyclohexane extraction, is made into the Fe that concentration is 1mg/ml 3o 4quantum dot ring hexane solution.
(4) coated silica: measure 3.7mlIgepalCO-520, by its ultrasonic disperse in the cyclohexane extraction of 60ml, then by 2mlZnS:Mn 2+the cyclohexane solution (5mg/ml) of QDs and 2mlFe 3o 4cyclohexane solution (1mg/ml) join in above-mentioned solution simultaneously, stirring 30min makes it be uniformly dispersed, after 0.5ml ammonia (25%) is added fast, stir after 1h in system, add 250 μ lTEOS, room temperature reaction 15-20h obtains ZnS:Mn 2+quantum dot/Fe 3o 4quantum dot/SiO 2nano composite material.End product ethanol, product for several times, then disperses preservation or 60 DEG C of dry 6h in ethanol to obtain grey-brown powder, obtains ZnS:Mn by deionized water wash 2+quantum dot/Fe 3o 4quantum dot/SiO 2nano composite material.
(5) silane coupler finishing: take 30mgZnS:Mn 2+quantum dot/Fe 3o 4quantum dot/SiO 2nano composite material is dispersed in the aqueous hydrochloric acid solution of 40mlPH=4, and ultrasonic 20min makes it be uniformly dispersed, and then dispersion liquid is added 85 DEG C of heating 1-2h in the three-neck flask of 250ml, obtains the ZnS:Mn of surface hydroxylation after the centrifugal 5min of 10000rpm 2+quantum dot/Fe 3o 4quantum dot/SiO 2nano composite material.2. measure the mixed solution (ethanol: water=4:1) of 40mlPH=4, add 0.2mlKH570, be placed on magnetic stirring apparatus and stir hydrolysis 2h.Add the ZnS:Mn of surface hydroxylation 2+quantum dot/Fe 3o 4quantum dot/SiO 2nano composite material, joins in the three-neck flask of 250ml by solution after ultrasonic disperse 30min, is placed on by three-neck flask in water-bath, at 70 DEG C, stir 5h, then water-bath temperature is brought up to 80-85 DEG C, continues to stir 1-2h.Carry out centrifugal to solution, utilize washing with alcohol 6 times, centrifugal products therefrom is dispersed in alcoholic solution to be preserved, and obtains the ZnS:Mn of KH570 surface modification 2+quantum dot/Fe 3o 4quantum dot/SiO 2alcoholic solution.
(6) surface grafting polymerization thing: the ZnS:Mn that KH570 step (5) synthesized modifies 2+quantum dot/Fe 3o 4quantum dot/SiO 2nano composite material deionized water wash three times, and be dispersed in 100ml deionized water for ultrasonic 20min, then joined in the four neck flasks of 250ml, and be placed in water-bath, add 0.150gNIPAAm wherein, the BIS of 9.4mgAAm and 0.015g, stirs at 200 rpm with mechanical agitation rod, and logical nitrogen deoxidation 0.5h.Then water-bath is warming up to 70 DEG C, adds KPS1.5ml (4mg/ml), the response time is 4h.Centrifugal and utilize deionized water wash three times, be then placed in the dry 24h of vacuum freeze drier and obtain target product ZnS:Mn 2+quantum dot/Fe 3o 4quantum dot/SiO 2/ PNIPAAm.
Embodiment 2
Embodiment 1 is optimal way of the present invention, except embodiment 1 except the method step that describes, micromodification of the addition of raw material and reaction condition being run business into particular one becomes, with reference to existing method with according to reaction principle analysis, disclosed in summary of the invention of the present invention, reaction condition changes the material alterations that all can not cause the inventive method, all can realize the present invention.As: in the embodiment of the present invention 1 when utilizing oleic acid to modify ferroso-ferric oxide surface, add the oleic acid of deionized water volume 15% ~ 50%, 20 ~ 60 DEG C of reactions 1 ~ 6 hour during reaction.The concrete steps of coated silica can with reference to prior art, and when further hydroxylating process, under the condition of pH=3 ~ 5,75 ~ 85 DEG C of heating 1 ~ 2h can realize the hydroxylating of surface silica dioxide.When heating uses silane coupler effects on surface to modify, the addition of KH570 is 0.1 ~ 0.2mL/40mL alcohol-water solution, and needs to carry out under the condition of PH=3 ~ 5.5.The present invention is ZnS:Mn in preparation process 2+quantum dot and Fe 3o 4the mass ratio of quantum dot better can ensure the effect of magnetic and fluorescence at 3:1 ~ 6:1.Add using and being controlled to be coated with extraordinary effect for silicon dioxide between 0.06 ~ 0.07:1 of surfactant IgepalCO-520, improve technique effect of the present invention.
Embodiment 3
Structure and fuction characterizes
The present invention characterizes from 26S Proteasome Structure and Function target product respectively, characterizes with the structure of transmission electron microscope mode to target product, and as shown in Figure 1, black region is ZnS:Mn 2+quantum dot or Fe 3o 4quantum dot, its surperficial dark gray areas is surface coated SiO 2, outermost layer light gray areas is PNIPAAm.
Functional characterization of the present invention is divided into temperature-sensing property sign, magnetic characterization and the characteristics of luminescence to characterize.
The present invention varies with temperature curve by light transmittance and characterizes its temperature-sensing property.As shown in Figure 2, the phase transition temperature of target product is 41.1 DEG C, is greater than the body temperature 37 DEG C of human body, therefore can be realized the controllable release of medicine by the temperature controlling carrier.
Fig. 3 is target product ZnS:Mn of the present invention 2+quantum dot/Fe 3o 4quantum dot/SiO 2the fluorescence emission spectrum of/PNIPAAm, as can be seen from Figure 3, the glow peak of target product is positioned at 592.7nm.The target sample aqueous solution of the present invention's brown under 365nm ultraviolet excitation condition sends glassy yellow fluorescence (as shown in figures 4 a and 4b).Target product ZnS:Mn is described 2+quantum dot/Fe 3o 4quantum dot/SiO 2/ PNIPAAm can as fluorescent marker application in vivo.
Can be seen by Fig. 5, target product of the present invention has superparamagnetism.Utilize Magnet to carry out targeting experiment (as shown in Figure 6) to solution, find that target product ZnS:Mn is assembled in solution side 2+quantum dot/Fe 3o 4quantum dot/SiO 2/ PNIPAAm, solution colour becomes milky by brown, and target product ZnS:Mn is described 2+quantum dot/Fe 3o 4quantum dot/SiO 2/ PNIPAAm can realize targeting and move under the effect of external magnetic field, realizes the location release of medicine.

Claims (6)

1. an optomagnetic temperature-sensitive nano combination drug carrier, is characterized in that: have SiO at Surface coating 2znS:Mn 2+quantum dot and Surface coating have SiO 2fe 3o 4the skin of quantum dot, is coated with PNIPAM, forms nano-complex.
2. a preparation method for optomagnetic temperature-sensitive nano combination drug carrier according to claim 1, concrete steps are as follows:
One, by Fe 3o 4quantum dot is scattered in water, Fe 3o 4the mass volume ratio of quantum dot and water is 15 ~ 120mg/ml, adds the oleic acid of water volume 15% ~ 50%, reacts 1 ~ 6h, obtain the Fe of oleic acid modified under 20 ~ 60 DEG C of conditions 3o 4quantum dot;
Two, by the Fe after oleic acid modified 3o 4quantum dot washing, dry, pulverize after be scattered in cyclohexane extraction, obtain Fe 3o 4quantum dot ring hexane solution;
Three, by ZnS:Mn 2+quantum dot is scattered in cyclohexane extraction, obtains ZnS:Mn 2+quantum dot ring hexane solution;
Four, by polyoxyethylenes (5) nonylplenyl ether, branching is scattered in cyclohexane extraction, polyoxyethylenes (5) nonylplenyl ether, and the addition volume ratio of branching and cyclohexane extraction is 0.06 ~ 0.07:1, adds ZnS:Mn 2+the cyclohexane solution of quantum dot and Fe 3o 4quantum dot ring hexane solution, is dispersed to evenly, and add ammonia and regulate pH to alkalescence, add the ethyl orthosilicate of cyclohexane extraction cumulative volume 0.15% ~ 0.8%, reaction 10 ~ 40h, obtains ZnS:Mn 2+quantum dot/Fe 3o 4quantum dot/SiO 2nano-complex, carries out washing after reaction terminates, dried; Wherein, the ZnS:Mn added 2+quantum dot ring hexane solution and Fe 3o 4znS:Mn in quantum dot ring hexane solution 2+quantum dot and Fe 3o 4the mass ratio of quantum dot is between 3:1 ~ 6:1;
Five, by ZnS:Mn 2+quantum dot/Fe 3o 4quantum dot/SiO 2nano-complex is dispersed in the aqueous hydrochloric acid solution of pH=3 ~ 5, and 75 ~ 85 DEG C of heating 1 ~ 2h, obtain the ZnS:Mn of surface hydroxylation 2+quantum dot/Fe 3o 4quantum dot/SiO 2nano-complex;
Six, configure the alcohol-water mixed solution of pH=3 ~ 5.5, add silane coupler KH570, after silane coupler KH570 is hydrolyzed, add the ZnS:Mn of surface hydroxylation 2+quantum dot/Fe 3o 4quantum dot/SiO 2nano-complex carries out finishing to it, under 70 ~ 85 DEG C of conditions, react 6 ~ 7h; Wherein, the addition of silane coupler KH570 is 0.25% ~ 0.5% of alcohol-water mixed solution cumulative volume; In described alcohol-water mixed solution, the volume ratio of second alcohol and water is 3 ~ 5:1;
Seven, silane coupler is modified ZnS:Mn 2+quantum dot/Fe 3o 4quantum dot/SiO 2nano-complex is scattered in water, adds monomer NIPA, acrylamide and N-N-methylene-bisacrylamide, in removing reaction system after oxygen at 70 ~ 80 DEG C, adding the initiator for reaction time is namely obtain ZnS:Mn after 4 ~ 6h 2+quantum dot/Fe 3o 4quantum dot/SiO 2/ PNIPAM nano-complex; Wherein, NIPA in mass ratio: acrylamide: N,N methylene bis acrylamide: silane coupler modifies ZnS:Mn 2+quantum dot/Fe 3o 4quantum dot/SiO 2nano-complex=4.5 ~ 5.5:0.3 ~ 0.35:0.4 ~ 0.6:1.
3. the preparation method of optomagnetic temperature-sensitive nano combination drug carrier according to claim 2, is characterized in that: after washing, drying, obtain pure ZnS:Mn after step 7 completes 2+quantum dot/Fe 3o 4quantum dot/SiO 2/ PNIPAM nano-complex.
4. the preparation method of optomagnetic temperature-sensitive nano combination drug carrier according to claim 2, is characterized in that: described initiator is potassium peroxydisulfate.
5. the preparation method of optomagnetic temperature-sensitive nano combination drug carrier according to claim 2, it is characterized in that: in step 6, under 70 ~ 85 DEG C of conditions, react 6 ~ 7h be two sections and carry out: first under 70 DEG C of conditions, react 5h, then temperature is brought up to 80 ~ 85 DEG C, continue reaction 1 ~ 2h.
6. the preparation method of optomagnetic temperature-sensitive nano combination drug carrier according to claim 2, is characterized in that: NIPA in step 7: acrylamide: N,N methylene bis acrylamide: silane coupler modifies ZnS:Mn 2+quantum dot/Fe 3o 4quantum dot/SiO 2nano-complex=5:0.31:0.5:1.
CN201510793864.8A 2015-11-18 2015-11-18 A kind of optomagnetic temperature-sensitive nano combination drug carrier and preparation method thereof Expired - Fee Related CN105381466B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510793864.8A CN105381466B (en) 2015-11-18 2015-11-18 A kind of optomagnetic temperature-sensitive nano combination drug carrier and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510793864.8A CN105381466B (en) 2015-11-18 2015-11-18 A kind of optomagnetic temperature-sensitive nano combination drug carrier and preparation method thereof

Publications (2)

Publication Number Publication Date
CN105381466A true CN105381466A (en) 2016-03-09
CN105381466B CN105381466B (en) 2019-04-09

Family

ID=55414636

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510793864.8A Expired - Fee Related CN105381466B (en) 2015-11-18 2015-11-18 A kind of optomagnetic temperature-sensitive nano combination drug carrier and preparation method thereof

Country Status (1)

Country Link
CN (1) CN105381466B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109277079A (en) * 2018-12-01 2019-01-29 浙江海洋大学 A kind of preparation method of the composite material of light sensitivity
CN109277091A (en) * 2018-12-01 2019-01-29 浙江海洋大学 A kind of preparation method of the composite material of Thermo-sensitive
CN110129025A (en) * 2019-05-14 2019-08-16 上海大学 The preparation method of simple Silica-coated quantum dot
CN115159587A (en) * 2022-07-21 2022-10-11 江苏先丰纳米材料科技有限公司 Preparation method of molybdenum trioxide nanosheet loaded ferroferric oxide magnetic nanoparticle

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102675565A (en) * 2012-05-09 2012-09-19 天津大学 Carbon quantum dot-poly N-isopropylacrylamide composite material and preparation method thereof
CN103204972A (en) * 2013-04-23 2013-07-17 上海师范大学 Thermo-sensitive fluorescent carbon nano composite material and preparation method thereof
CN103239410A (en) * 2013-05-02 2013-08-14 上海交通大学 Preparation method of fluorescence and heat/pH sensitive organic-inorganic composite microsphere carrier
CN103386135A (en) * 2013-07-24 2013-11-13 上海交通大学 Preparation method of multifunctional medicine carrier integrating magnetism, fluorescence and thermosensitivity

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102675565A (en) * 2012-05-09 2012-09-19 天津大学 Carbon quantum dot-poly N-isopropylacrylamide composite material and preparation method thereof
CN103204972A (en) * 2013-04-23 2013-07-17 上海师范大学 Thermo-sensitive fluorescent carbon nano composite material and preparation method thereof
CN103239410A (en) * 2013-05-02 2013-08-14 上海交通大学 Preparation method of fluorescence and heat/pH sensitive organic-inorganic composite microsphere carrier
CN103386135A (en) * 2013-07-24 2013-11-13 上海交通大学 Preparation method of multifunctional medicine carrier integrating magnetism, fluorescence and thermosensitivity

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GE LIU等: "Multifunctional PNIPAM/Fe3O4–ZnS hybrid hollow spheres: Synthesis, characterization, and properties", 《JOURNAL OF COLLOID AND INTERFACE SCIENCE》 *
JIAN CAO等: "Effects of surface modification and SiO2 thickness on the optical and superparamagnetic properties of the water-soluble ZnS:Mn2+ nanowires/Fe3O4 quantum dots/SiO2 heterostructures", 《CRYSTENGCOMM》 *
SUBRAMANIAN TAMIL SELVAN等: "Functional and Multifunctional Nanoparticles for Bioimaging and Biosensing", 《LANGMUIR》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109277079A (en) * 2018-12-01 2019-01-29 浙江海洋大学 A kind of preparation method of the composite material of light sensitivity
CN109277091A (en) * 2018-12-01 2019-01-29 浙江海洋大学 A kind of preparation method of the composite material of Thermo-sensitive
CN110129025A (en) * 2019-05-14 2019-08-16 上海大学 The preparation method of simple Silica-coated quantum dot
CN115159587A (en) * 2022-07-21 2022-10-11 江苏先丰纳米材料科技有限公司 Preparation method of molybdenum trioxide nanosheet loaded ferroferric oxide magnetic nanoparticle

Also Published As

Publication number Publication date
CN105381466B (en) 2019-04-09

Similar Documents

Publication Publication Date Title
CN105381466A (en) Photo-magnetic and temperature-sensitive nano-composite drug carrier and preparation method thereof
CN102051177B (en) Water-soluble fluorescent magnetic nano particles and preparation method thereof
CN100425627C (en) Preparation process of magnetic partical/polymer/silicon dioxide structure magnetic microball
CN104745192B (en) A kind of magnetic fluorescent dual-function nanoparticle probe and preparation method thereof
CN101323022B (en) Method for preparing gold magnetic core-shell nano-particle
CN102718931B (en) Preparation method of superparamagnetic composite microballoons used in biomedicine
CN104762085B (en) A kind of magnetic fluorescence composite Nano bioprobe and preparation method thereof
Xiong et al. Remote and real time control of an FVIO–enzyme hybrid nanocatalyst using magnetic stimulation
CN101797387A (en) Magnetic targeting carrier capable of carrying gene and drug, preparation method and application thereof
CN102234507A (en) Preparation of fluorescent silicon dioxide nanospheres
CN104237503A (en) Mitochondria targeted fluorescent labeling magnetic nano material as well as preparation method and application of mitochondria targeted fluorescent labeling magnetic nano material
CN107522239A (en) A kind of method based on gallic acid metallic ion coordination chemical regulation nano ferriferrous oxide decentralization and particle diameter
CN100573750C (en) Double cladding water-based magnetofluid and preparation method thereof
CN104465000A (en) Preparation method for ferroferric oxide magnetic mesoporous material wrapped by zinc oxide
Liu et al. A facile fabrication of spherical and beanpod-like magnetic-fluorescent particles with targeting functionalities
Heng et al. DNA aptamer functionalized monodisperse Eu/Mn-WH nanoparticle for in vivo magnetic resonance and fluorescence imaging
CN103479999B (en) Water-soluble automatic temperature control ferrite nano particles of covalent coupling antibody and method for preparing same
CN103272541B (en) Method for preparing magnetic silicon oxide polymer composite microspheres with asymmetrical structure and surface anisotropic bifunctional groups
CN104740653A (en) Hollow mesoporous silica-DNA composite material and preparation method and application thereof
Wang et al. In situ magnetization technique for synthesis of magnetic polymer microspheres
CN102294039A (en) Preparation method of yolk-eggshell nanocapsule with fluorescence and magnetism
CN107158413B (en) Nano metal oxide modified ultrasonic contrast agent and preparation method thereof
Wang et al. One-pot synthesis of Fe3O4@ PS@ P (AEMH-FITC) magnetic fluorescent nanocomposites for bimodal imaging
CN106668880B (en) The application of ultrasound/magnetic resonance bimodal contrast agent
CN110724518B (en) Fe applicable to dual-mode imaging system 3 O 4 @CuInS 2 Construction of core-shell structures

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20190409

Termination date: 20191118